Prof. Stephen M. Sammut
Founder and President, Pangea University for the Health Sciences
In his academic life, Steve is Senior Fellow, Health Care Management and Lecturer, Entrepreneurship at the Wharton School.
During his 24 years teaching at Wharton and other schools, he has created over a dozen courses that he has taught to over 10,000 students.
His research focuses on international development and health care and biotechnology capacity development in emerging economies, as well as business model innovation in biotechnology.
He has published articles in Nature Biotechnology, the New England Journal of Medicine, the Journal of Commercial Biotechnology and has authored numerous book chapters on health care and biotechnology. Steve recently founded Pangea University for the Health Sciences as a vehicle for providing training for health service professionals.
He is visiting faculty and coordinator of the Indian School of Business healthcare program and visiting faculty at the Strathmore Business School in Nairobi where he founded the first Healthcare Management MBA program on the African continent, as well as founding the African Institute for Healthcare Management, an organization focused on developing faculty and teaching materials to advance health services.
He is currently developing a School of Global Public Health at Strathmore University. His board memberships include the Center for Medicine in the Public Interest and BioEthics International. He is a member of the Advisory Panel at the Abraaj Africa Health Fund and numerous companies in the United States and India. He is also Senior Advisor to the Excelsior Group in Nairobi, a health care consultancy.
He currently advises several venture capital and global private equity funds. He was a Venture Partner at Burrill & Company until 2008. He consults for the IFC/World Bank on PE/VC and technology transfer. Earlier he was VP, SR One, the venture capital arm of GSK, and VP for Development and Private Equity at Teleflex Incorporated.
He currently advises several venture capital and global private equity funds. He was a Venture Partner at Burrill & Company until 2008. He consults for the IFC/World Bank on PE/VC and technology transfer.
Qualifications
Doctoral Candidate at the Fox School of Business at Temple University.
MBA from Wharton School.
Graduate and Undergraduate degrees from Villanova University.
In his private sector life, Steve has founded, managed or financed over 40 companies in life sciences and IT globally. Earlier he was VP, SR One, the venture capital arm of GSK, and VP for Development and Private Equity at Teleflex Incorporated.
He has also been Managing Director of Technology Transfer at the University of Pennsylvania and Thomas Jefferson University. He began his career as co-founder and CEO of the Philadelphia transplant organ bank.
His research focuses on:
- International Development and Healthcare
- Biotechnology Capacity Development in Emerging Economies
- Business Model Innovation in Biotechnology
He has published articles in Nature Biotechnology, the New England Journal of Medicine, the Journal of Commercial Biotechnology and has authored numerous book chapters on health care and biotechnology.
